Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood
Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood
Loading...
Date
2009
Authors
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published
Published in
Alternatives to Animal Experimentation : ALTEX ; 26 (2009), 4. - pp. 265-277. - ISSN 1868-596X. - eISSN 1868-8551
Abstract
Microorganisms such as Gram-negative or Gram-positive bacteria, viruses and fungi contain components that activate the innate immune system. These components, called pyrogens (Greek: pyros=fire), can occur independently of viable microorganisms and are a major safety concern in parenterally administered drugs, since they can cause severe reactions such as fever, organ failure, and shock in the recipient. So far these drugs have been tested by injecting them intravenously into rabbits and measuring their fever reaction or, alternatively, by the Limulus Amoebocyte Lysate (LAL) test, employing the coagulation of the hemolymph lysate of Limulus polyphemus. Both tests have inherent limitations. A new in vitro monocyte activation test (MAT) based on human whole blood, capable of measuring all pyrogens relevant to the human patient, introduced in this journal in 1995, was validated and recently accepted by European Pharmacopoeia and US FDA. This review describes its principle, development, validation and the wide spectrum of applications, such as for testing of medical devices, blood products, toxic or immunomodulatory drugs, dialysis liquids, lipidic parenterals, and air quality. This alternative method promises to replace the rabbit pyrogen test fully and to overcome several limitations of the LAL assay.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
SCHINDLER, Stefanie, Sonja von AULOCK, Mardas DANESHIAN, Thomas HARTUNG, 2009. Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. In: Alternatives to Animal Experimentation : ALTEX. 26(4), pp. 265-277. ISSN 1868-596X. eISSN 1868-8551. Available under: doi: 10.14573/altex.2009.4.265BibTex
@article{Schindler2009Devel-38603, year={2009}, doi={10.14573/altex.2009.4.265}, title={Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood}, number={4}, volume={26}, issn={1868-596X}, journal={Alternatives to Animal Experimentation : ALTEX}, pages={265--277}, author={Schindler, Stefanie and Aulock, Sonja von and Daneshian, Mardas and Hartung, Thomas} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/38603"> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/38603/1/Schindler_0-403473.pdf"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/> <dc:language>eng</dc:language> <dc:creator>Aulock, Sonja von</dc:creator> <dc:contributor>Daneshian, Mardas</dc:contributor> <dcterms:title>Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood</dcterms:title> <dc:contributor>Hartung, Thomas</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Schindler, Stefanie</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/> <dcterms:issued>2009</dcterms:issued> <dc:creator>Daneshian, Mardas</dc:creator> <dc:creator>Hartung, Thomas</dc:creator> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/38603/1/Schindler_0-403473.pdf"/> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/38603"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-25T09:23:28Z</dc:date> <dc:rights>Attribution 4.0 International</dc:rights> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dcterms:abstract xml:lang="eng">Microorganisms such as Gram-negative or Gram-positive bacteria, viruses and fungi contain components that activate the innate immune system. These components, called pyrogens (Greek: pyros=fire), can occur independently of viable microorganisms and are a major safety concern in parenterally administered drugs, since they can cause severe reactions such as fever, organ failure, and shock in the recipient. So far these drugs have been tested by injecting them intravenously into rabbits and measuring their fever reaction or, alternatively, by the Limulus Amoebocyte Lysate (LAL) test, employing the coagulation of the hemolymph lysate of Limulus polyphemus. Both tests have inherent limitations. A new in vitro monocyte activation test (MAT) based on human whole blood, capable of measuring all pyrogens relevant to the human patient, introduced in this journal in 1995, was validated and recently accepted by European Pharmacopoeia and US FDA. This review describes its principle, development, validation and the wide spectrum of applications, such as for testing of medical devices, blood products, toxic or immunomodulatory drugs, dialysis liquids, lipidic parenterals, and air quality. This alternative method promises to replace the rabbit pyrogen test fully and to overcome several limitations of the LAL assay.</dcterms:abstract> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-25T09:23:28Z</dcterms:available> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:contributor>Aulock, Sonja von</dc:contributor> <dc:contributor>Schindler, Stefanie</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes